CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The osteoprotegerin (OPG)/receptor activator of nuclear factor-κB ligand (RANKL)/receptor activator of nuclear factor-κB (RANK) system was evaluated as a potential target of CGRP anabolic activity on bone. Primary cultures of human osteoblast-like cells (hOB) express calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1, and, because CGRP stimulates cAMP (one of the modulators of OPG production in osteoblasts), it was investigated whether it affects OPG secretion and expression in hOB. CGRP treatment of hOB (10−11 M–10−7 M) dose-dependently inhibited OPG secretion with an EC 50 of 1.08 × 10−10 M, and also decreased its expression. This action was blocked by the antagonist CGRP 8–37. Forskolin, a stimulator of cAMP production, and dibutyryl cAMP also reduced the production of OPG. CGRP (10−8 M) enhanced protein kinase A (PKA) activity in hOB, and hOB exposure to the PKA inhibitor, H89 (2 × 10−6 M), abolished the inhibitory effect of CGRP on OPG secretion. Conditioned media from CGRP-treated hOB increased the number of multinucleated tartrate-resistant acid phosphatase-positive cells and the secretion of cathepsin K in human peripheral blood mononuclear cells compared with the conditioned media of untreated hOB. These results show that the cAMP/PKA pathway is involved in the CGRP inhibition of OPG mRNA and protein secretion in hOB and that this effect favors osteoclastogenesis. CGRP could thus modulate the balance between osteoblast and osteoclast activity, participating in the fine tuning of all of the bone remodeling phases necessary for the subsequent anabolic effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134 · cited 2×
“The coexpression of CLR and RAMP2 gives rise to a receptor with greater affinity for adrenomedullin (23, 29), a member of the calcitonin peptide family, which, like CGRP, has mitogenic effects on osteoblasts (9).”
BackgroundYasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201
Theoleyre, S., Wittrant, Y., Tat, S. K., Fortun, Y., Redini, F., & Heymann, D. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.06.004 · Cited by 663
Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption.
Nakamura, M., Udagawa, N., Matsuura, S., Mogi, M., Nakamura, H., Horiuchi, H., Saito, N., Hiraoka, B. Y., Kobayashi, Y., Takaoka, K., et al. (2003) · Endocrinology · doi:10.1210/en.2003-0717 · Cited by 191
Decreased Bone Formation and Osteopenia in Mice Lacking α-Calcitonin Gene-Related Peptide
Schinke, T., Liese, S., Priemel, M., Haberland, M., Schilling, A. F., Catala-Lehnen, P., Blicharski, D., Rueger, J. M., Gagel, R. F., Emeson, R. B., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040915 · Cited by 177
Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development
Cornish, J., Callon, K. E., Bava, U., Kamona, S. A., Cooper, G. J. S., & Reid, I. R. (2001) · Bone · doi:10.1016/s8756-3282(01)00494-x · Cited by 173 · cited 1×
“The finding that CGRP favors osteoclast formation via its pro-osteoclastogenic effect on the OPG/RANK/RANKL triad apparently conflicts with its direct inhibitory action on bone resorption (1, 8, 21, 49).”
BackgroundTargeted Expression of Calcitonin Gene-Related Peptide to Osteoblasts Increases Bone Density in Mice
Ballica, R., Valentijn, K., Khachatryan, A., Guerder, S., Kapadia, S., Gundberg, C., Gilligan, J., Flavell, R. A., & Vignery, A. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.7.1067 · Cited by 133
Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease.
Taranta, A., Fortunati, D., Longo, M., Rucci, N., Iacomino, E., Aliberti, F., Facciuto, E., Migliaccio, S., Bardella, M. T., Dubini, A., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040319 · Cited by 118
A Potential Role for Adrenomedullin as a Local Regulator of Bone Growth1
Naot, D., Callon, K. E., Grey, A., Cooper, G. J. S., Reid, I. R., & Cornish, J. (2001) · Endocrinology · doi:10.1210/endo.142.5.8152 · Cited by 54 · cited 1×
“At variance with published findings of the expression of all three RAMPs in primary cultures of fetal rat osteoblasts (35), the lack of RAMP3 expression in hOB indicates that the expression of this family of proteins is species specific.”
Background
Cited by
Wang, L., Shi, X., Zhao, R., Halloran, B. P., Clark, D. J., Jacobs, C. R., & Kingery, W. S. (2010) · Bone · doi:10.1016/j.bone.2009.11.029 · Cited by 198
“CRL and RAMP1 receptors are expressed in mature osteoblasts [10–14].”
BackgroundHallmarks of peripheral nerve function in bone regeneration
Tao, R., Mi, B., Hu, Y., Lin, S., Xiong, Y., Lu, X., Panayi, A. C., Li, G., & Liu, G. (2023) · Bone Research · doi:10.1038/s41413-022-00240-x · Cited by 110
Mrak, E., Guidobono, F., Moro, G., Fraschini, G., Rubinacci, A., & Villa, I. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22266 · Cited by 97
Self-citationTian, G., Zhang, G., & Tan, Y.-H. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.41 · Cited by 61
Xu, J., Kauther, M. D., Hartl, J., Wedemeyer, C., & Study was performed at the University of Duisburg - Essen, G. (2010) · Journal of Orthopaedic Surgery and Research · doi:10.1186/1749-799x-5-83 · Cited by 18
Metadata
- Authors
- Villa, I., Mrak, E., Rubinacci, A., Ravasi, F., & Guidobono, F.
- Venue
- American Journal of Physiology-Cell Physiology
- Publisher
- American Physiological Society
- Published
- 2006-09
- Volume
- 291
- Issue
- 3
- Pages
- C529-C537
- ISSN
- 0363-6143 (ISSN-L)
- 1522-1563
- OpenAlex
- W2100898690
- Cited by
- 68
- References
- 9
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway. https://app.cochat.ai/papers/10.1152/ajpcell.00354.2005
- The paper
- Villa, I., Mrak, E., Rubinacci, A., Ravasi, F., & Guidobono, F. (2006). CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00354.2005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.